Bookmark
Forward
Letter to the Editor: Saroglitazar for Treatment of NAFLD and NASH.
Karan Kumar, Anand Kulkarni, Rakesh Kumar Jagdish
Hepatology (Baltimore, Md.) 2021 Dec
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Karan Kumar, Anand Kulkarni, Rakesh Kumar Jagdish.
Letter to the Editor: Saroglitazar for Treatment of NAFLD and NASH.
Hepatology (Baltimore, Md.).
2021 Dec;74(6):3559-3560
Mesh Tags
Humans
Non-alcoholic Fatty Liver Disease
Phenylpropionates
Pyrroles
Substances
Phenylpropionates
Pyrroles
saroglitazar
PMID: 34365663
View Full Text